Side-by-side comparison of AI visibility scores, market position, and capabilities
Haleon (HLN) world's #1 sensitive teeth toothpaste in 130+ countries; $2B+ revenue with clinical desensitizing formulas and dentist-recommended positioning competing with Colgate Sensitive.
Sensodyne is the world's #1 dentist-recommended toothpaste brand for sensitive teeth — owned by Haleon plc (LSE/NYSE: HLN), the consumer healthcare company spun out of GlaxoSmithKline in 2022. Sensodyne's clinically proven formulations (potassium nitrate or stannous fluoride as active desensitizing ingredients) treat and prevent tooth sensitivity while providing cavity protection, enamel strengthening, and whitening benefits. Available in 130+ countries and generating approximately $2+ billion in annual retail sales, Sensodyne is Haleon's largest brand and one of the world's most profitable consumer healthcare products.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.